Terminalia chebula Retz.,
Terminalia bellirica (Gaertn.) Roxb. and
Phyllanthus emblica Linn. were purchased from Zhongyong Pharmaceutical Co., Ltd. (Sichuan, China). All herbs were identified by Professor Jin Pei, deposited at the Chengdu University of TCM, and met Chinese Pharmacopoeia requirements (2015 Edition). Standards of Chebulic acid (CHB180831),
Gallic acid (CHB171107), Punicalin (CHB190211),
Catechin (CHB170301), Epigallo
Catechin gallate (CHB180307), Epi
Catechin (CHB180831), Corilagin (CHB190106), Gallo
Catechin gallate (CHB180327), 1,3,6-tri-O-galloylglucose (CHB191021), Epi
Catechin gallate (CHB170317),
Ferulic acid (CHB 180201), Chebulagic acid (CHB190109), 1,2,3,4,6-O-penta-galloyl glucose (CHB190125), Chebulinic acid (CHB190124), and
Ellagic acid (CHB170303) were purchased from Chengdu Chroma-Biotechnology Co., Ltd. (Chengdu, China), the purity of all standard products is ≥ 98%. CCl
4 (20181010) was purchased from Tianjin Bodi Chemical Co., Ltd. (Tianjin, China), Dimethyl diphenyl bicarboxylate (DDB) (200603) was purchased from Bond Pharmaceuticals Group Co., Ltd. (Wenling, China). Test kits for ALT (20191003), AST (20191005), SOD (20191101), MDA (20191028), and
GSH-Px (20191029) were obtained from Nanjing Jiancheng Bioengineering Institute (Nanjing, China). TNF-α (A28291045) and
IL-6 (A20691132) were obtained by Multi Sciences Biotech Co., Ltd. (Hangzhou, China).
Wei X., Luo C., He Y., Huang H., Ran F., Liao W., Tan P., Fan S., Cheng Y., Zhang D., Lin J, & Han L. (2021). Hepatoprotective Effects of Different Extracts From Triphala Against CCl4-Induced Acute Liver Injury in Mice. Frontiers in Pharmacology, 12, 664607.